Skip to content

Clinical application of electroacupuncture assisted Opioid-sparing anesthesia in laparoscopic abdominal surgery

Clinical application of electroacupuncture assisted Opioid-sparing anesthesia in laparoscopic abdominal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000289
Enrollment
Unknown
Registered
2024-08-24
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases that require major abdominal surgery, including colorectal cancer, gastric cancer, liver cancer, etc

Interventions

Electroacupuncture group (E group):30 minutes before anesthesia induction, electroacupuncture treatment was performed at the Zusanli, Neiguan, Hegu, and Sanyinjiao acupoints (bilateral) of the patient
Remifentanil group(R):Continuously pump remifentanil 0.2-0.5 µ g/kg/h after anesthesia induction until 10 minutes before the end of the operation

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1: Patients undergoing elective laparoscopic abdominal surgery 2: Age range: 18-65 years old; 3: BMI:18.5-28kg/m2; 4: No serious systemic diseases; 5: No history of medication or electroacupuncture allergies.

Exclusion criteria

Exclusion criteria: 1: Has developed distant metastasis, other organs have malignant tumors, and received preoperative radiotherapy, chemotherapy, or immunotherapy; 2: Suffering from autoimmune diseases and having received treatment with glucocorticoids or immunosuppressants within one year; 3: Serious neurological disorders, liver diseases, kidney failure, or ASA score IV or above; 4: History of major surgery within 1 year; 5: Preoperative use of opioid drugs in patients; 6: There are infected individuals in the relevant acupoints.

Design outcomes

Primary

MeasureTime frame
NRS;

Secondary

MeasureTime frame
Postoperative hospitalization days;PSQI;Surgical anesthesia medication dosage;Post-Operative Quality of Recovery Scale (PQRS);Postoperative recurrence free survival and overall survival;Postoperative complications at 30 and 90 days;

Countries

CHINA

Contacts

Public ContactWu jianwei

Guangdong Provincial Hospital of Chinese Medicine

wujianwei97@163.com+86 15876500650

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026